美国联邦医疗保险受益人中5年死亡率预测模型的外部验证
本研究在美国全国联邦医疗保险(Medicare)受益人中外部验证了基于理赔数据的Lund-Lewis 5年死亡率预测模型。
要点
- 重分类指标显示模型对死亡受益人的预测优于合并症评分模型,但对存活者预测变差。
核心结论
- Lund-Lewis 5年死亡率模型在美国全国Medicare样本中表现出强且一致的区分度。
- 模型校准显示轻度过拟合,普遍高估死亡风险。
- 未来需研究改善模型校准及在特定疾病环境中评估性能的方法。
研究设计与样本
- 回顾性外部验证研究,采用美国全国Medicare受益人随机样本。
- 结局为5年全因死亡率,临床指标评估于合格门诊就诊前12个月。
- 将原始北卡罗来纳队列估计值应用于全国样本以计算预测5年死亡率。
- 通过区分度、校准和重分类指标评估模型性能,并与基于合并症评分的模型比较。
主要发现
- 各年度队列5年死亡率范围为24.4%至25.5%。
- 重分类指标显示模型对死亡受益人的预测优于合并症评分模型,但对存活受益人预测性能降低。
关键数值与推荐
- 模型预测5年死亡率在各年度队列中观察值为24.4%至25.5%。
临床怎么用
- 该模型可用于全国Medicare受益人5年死亡风险的区分性评估。
- 临床使用时需注意模型可能高估死亡风险,应结合校准情况解读预测值。
- 模型对死亡高风险受益人的识别优于合并症评分模型,但可能过度识别存活者。
局限性
- 模型校准显示轻度过拟合,普遍高估风险。
- 重分类改善仅见于死亡受益人,存活受益人预测性能降低。
- 研究未评估模型在特定疾病环境中的性能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVES: A claims-based model predicting 5-year mortality (Lund-Lewis) was developed in a 2008 cohort of North Carolina (NC) Medicare beneficiaries and included indicators of comorbid conditions, frailty, disability, and functional impairment. The objective of this study was to validate the Lund-Lewis model externally within a nationwide sample of Medicare beneficiaries. DESIGN: Retrospective validation study. SETTING: U.S. Medicare population. PARTICIPANTS: From a random sample of Medicare beneficiaries, we created four annual cohorts from 2008 to 2011 of individuals aged 66 and older with an office visit in that year. The annual cohorts ranged from 1.13 to 1.18 million beneficiaries. MEASUREMENTS: The outcome was 5-year all-cause mortality. We assessed clinical indicators in the 12 months before the qualifying office visit and estimated predicted 5-year mortality for each beneficiary in the nationwide sample by applying estimates derived in the original NC cohort. Model performance was assessed by quantifying discrimination, calibration, and reclassification metrics compared with a model fit on a comorbidity score. RESULTS: Across the annual cohorts, 5-year mortality ranged from 24.4% to 25.5%. The model had strong discrimination (C-statistics ranged across cohorts from .823 to .826). Reclassification measures showed improvement over a comorbidity score model for beneficiaries who died but reduced performance among beneficiaries who survived. The calibration slope ranged from .83 to .86; the model generally predicted a higher risk than observed. CONCLUSION: The Lund-Lewis model showed strong and consistent discrimination in a national U.S. Medicare sample, although calibration indicated slight overfitting. Future work should investigate methods for improving model calibration and evaluating performance within specific disease settings.
引用
- Ross RK, Kuo TM, Webster-Clark M, et al. Validation of a 5-Year Mortality Prediction Model among U.S. Medicare Beneficiaries. J Am Geriatr Soc. 2020. PMID: 32889756. doi:10.1111/jgs.16816
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。